Development and Validation Of Highly Sensitive Mrdx BCR-ABL Test For Monitoring Deep Molecular Response In Patients With Chronic Myeloid LeukemiaJulie Toplin, Chad Galderisi, Jonathan Eibl et al.|Blood|2013Cited by 2